Forward Clinical Trials, Inc.

Tampa, Florida 33624

0 studies enrolling now · 14 studies all time

What they study most

Actinic Keratosis, Alopecia Areata, Atopic Dermatitis, Chronic Plaque Psoriasis, Dermatitis Eczema, Dermatitis, Atopic, Dermatitis, Eczematous, Parapsoriasis, Plaque Psoriasis, Psoriasis

Studies at this site

• TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. — Completed
• A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis — Completed
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) — Completed
• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis — Completed
• Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp — Completed
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) — Completed
• A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata — Completed
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis — Completed
• Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis — Completed
• Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis — Completed